Table 3.
Predicted correlations between changes in the plasma levels of DPP-4, BGL and HBA1c and changes in plasma levels of citrus bioflavonoids following MedDiet intervention.
| Variables | Estimated Regression Weight * (S.E.) | p Value |
|---|---|---|
| Changes in the plasma levels of DPP-4 following MedDiet intervention | ||
| Hesperitin | −0.88 (0.31) | 0.005 |
| Hesperidin | −0.97 (1.41) | 0.48 |
| Naringin | 0.12 (0.14) | 0.4 |
| Naringenin | 21.37 (25.85) | 0.4 |
| Rutin | −0.022 | 0.26 |
| Changes in the plasma levels of BGL following MedDiet intervention | ||
| Hesperitin | 524.40 (1.28) | <0.001 |
| Hesperidin | 506.90 (4.91) | <0.001 |
| Naringin | −176.70 (0.51) | <0.001 |
| Naringenin | 150,922 (90.43) | <0.001 |
| Rutin | 60.90 (0.06) | <0.001 |
| Changes in the plasma levels of HbA1c following MedDiet intervention | ||
| Hesperitin | 733.80 (97.81) | <0.001 |
| Hesperidin | 458.80 (369.70) | 0.22 |
| Naringin | −259.90 (38.84) | <0.001 |
| Naringenin | 178,300 (6801.56) | <0.001 |
| Rutin | 79.70 (5.22) | <0.001 |
* Estimated regression weights obtained using structural equation modelling. S.E, standard error; DDP-4, dipeptidyl-peptidase 4; BGL, blood glucose levels; HbA1c, haemoglobin A1c.